Literature DB >> 27229750

Pulmonary function tests, interstitial lung disease and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis.

M D George1, R Shah2,3, M Kreider2, W T Miller4, P A Merkel1,5, V P Werth6.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27229750      PMCID： PMC5124547          DOI： 10.1111/bjd.14771

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

1.  Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations.

Authors:  Pamela A Morganroth; Mary Elizabeth Kreider; Joyce Okawa; Lynne Taylor; Victoria P Werth
Journal:  Arch Dermatol       Date:  2010-07

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

3.  Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody.

Authors:  Hua Cao; Meng Pan; Yanqing Kang; Qunli Xia; Xia Li; Xiaoqing Zhao; Ruofei Shi; Jianghua Lou; Min Zhou; Masataka Kuwana; Xiaoyi Ding; Jie Zheng
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

Review 4.  Pulmonary manifestations of polymyositis/dermatomyositis.

Authors:  Robert W Hallowell; Dana P Ascherman; Sonye K Danoff
Journal:  Semin Respir Crit Care Med       Date:  2014-03-25       Impact factor: 3.119

5.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

Authors:  E H Kang; E B Lee; K C Shin; C H Im; D H Chung; S K Han; Y W Song
Journal:  Rheumatology (Oxford)       Date:  2005-06-21       Impact factor: 7.580

Review 6.  Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.

Authors:  Richard D Sontheimer
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

7.  Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Shinji Sato; Masataka Kuwana; Rohit Aggarwal
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-05       Impact factor: 4.794

8.  Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.

Authors:  Hiroshi Mukae; Hiroshi Ishimoto; Noriho Sakamoto; Shintaro Hara; Tomoyuki Kakugawa; Seiko Nakayama; Yuji Ishimatsu; Atsushi Kawakami; Katsumi Eguchi; Shigeru Kohno
Journal:  Chest       Date:  2009-07-06       Impact factor: 9.410

9.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  I-Jung Chen; Yeong-Jian Jan Wu; Cho-Wei Lin; Kang-Wei Fan; Shue-Fen Luo; Huei-Huang Ho; Lieh-Bang Liou; Wen-Pin Tsai; Ji-Yih Chen; Chung-Han Yang; Chang-Fu Kuo; Kuang-Hui Yu
Journal:  Clin Rheumatol       Date:  2009-02-27       Impact factor: 2.980

10.  Prognostic factors for myositis-associated interstitial lung disease.

Authors:  Tomoyuki Fujisawa; Hironao Hozumi; Masato Kono; Noriyuki Enomoto; Dai Hashimoto; Yutaro Nakamura; Naoki Inui; Koshi Yokomura; Naoki Koshimizu; Mikio Toyoshima; Toshihiro Shirai; Kazumasa Yasuda; Hiroshi Hayakawa; Takafumi Suda
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240
  10 in total
  3 in total

Review 1.  MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis.

Authors:  Richard D Sontheimer
Journal:  Ann Transl Med       Date:  2017-04

Review 2.  Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis.

Authors:  Victoria P Werth; Anca D Askanase; Ingrid E Lundberg
Journal:  Int J Womens Dermatol       Date:  2021-09-24

3.  Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department.

Authors:  Keyun Tang; Hanlin Zhang; Hongzhong Jin
Journal:  Front Med (Lausanne)       Date:  2021-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.